ArticleJournal of acquired immune deficiency syndromes (1999)2017

The Second-Generation Maturation Inhibitor GSK3532795 Maintains Potent Activity Toward HIV Protease Inhibitor-Resistant Clinical Isolates.

Neelanjana Ray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.